Literature DB >> 24940911

Regulation of chemokine expression in the tumor microenvironment.

Anton V Gorbachev1, Robert L Fairchild2.   

Abstract

Chemokines are chemotactic cytokines critical for homeostatic and inflammation-induced trafficking of leukocytes during immune responses, hematopoesis, wound healing, and tumorigenesis. Despite three decades of intensive study of the chemokine network, the molecular mechanisms regulating chemokine expression during tumor growth are not well understood. In this review, we focus on the role of chemokines in both tumor growth and anti-tumor immune responses and on molecular mechanisms employed by tumor cells to regulate chemokine expression in the tumor microenvironment. Multiple mechanisms used by tumors to regulate chemokine production, including those revealed by very recent studies (such as DNA methylation or post-translational nitrosylation of chemokines) are discussed. Concluding the review, we discuss how understanding of these regulatory mechanisms can be used in cancer therapy to suppress tumor growth and/or to promote immune-mediated eradication of tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24940911      PMCID: PMC7191635          DOI: 10.1615/critrevimmunol.2014010062

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  112 in total

Review 1.  The chemokine system: redundancy for robust outputs.

Authors:  A Mantovani
Journal:  Immunol Today       Date:  1999-06

2.  Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

Authors:  Maria Grazia Borrello; Luisella Alberti; Andrew Fischer; Debora Degl'innocenti; Cristina Ferrario; Manuela Gariboldi; Federica Marchesi; Paola Allavena; Angela Greco; Paola Collini; Silvana Pilotti; Giuliana Cassinelli; Paola Bressan; Laura Fugazzola; Alberto Mantovani; Marco A Pierotti
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

3.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

4.  Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.

Authors:  P Proost; E Schutyser; P Menten; S Struyf; A Wuyts; G Opdenakker; M Detheux; M Parmentier; C Durinx; A M Lambeir; J Neyts; S Liekens; P C Maudgal; A Billiau; J Van Damme
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

5.  Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.

Authors:  D A Dixon; N D Tolley; P H King; L B Nabors; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.

Authors:  Adam W Mailloux; Anna-Maria A Clark; M Rita I Young
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

7.  Cutaneous tumors cease CXCL9/Mig production as a result of IFN-γ-mediated immunoediting.

Authors:  Marianne Petro; Danielle Kish; Olga A Guryanova; Galina Ilyinskaya; Anna Kondratova; Robert L Fairchild; Anton V Gorbachev
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

Review 8.  Cancer CXC chemokine networks and tumour angiogenesis.

Authors:  Robert M Strieter; Marie D Burdick; Javier Mestas; Brigitte Gomperts; Michael P Keane; John A Belperio
Journal:  Eur J Cancer       Date:  2006-02-28       Impact factor: 9.162

9.  Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Yasushi Sawanobori; Satoshi Ueha; Makoto Kurachi; Takeshi Shimaoka; James E Talmadge; Jun Abe; Yusuke Shono; Masahiro Kitabatake; Kazuhiro Kakimi; Naofumi Mukaida; Kouji Matsushima
Journal:  Blood       Date:  2008-03-28       Impact factor: 22.113

10.  Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.

Authors:  W T Arscott; A E LaBauve; V May; U V Wesley
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

View more
  17 in total

1.  Cell surface nucleolin interacts with CXCR4 receptor via the 212 c-terminal portion.

Authors:  Hongxin Niu; Xiangshan Yang; Zhongfa Xu; Tong Du; Ruogu Wang
Journal:  Tumour Biol       Date:  2014-10-19

2.  Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.

Authors:  Janis V de la Iglesia; Robbert J C Slebos; Laura Martin-Gomez; Xuefeng Wang; Jamie K Teer; Aik Choon Tan; Travis A Gerke; Garrick Aden-Buie; Tessa van Veen; Jude Masannat; Ritu Chaudhary; Feifei Song; Michelle Fournier; Erin M Siegel; Matthew B Schabath; J Trad Wadsworth; Jimmy Caudell; Louis Harrison; Bruce M Wenig; Jose Conejo-Garcia; Juan C Hernandez-Prera; Christine H Chung
Journal:  Clin Cancer Res       Date:  2019-12-17       Impact factor: 12.531

3.  Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.

Authors:  Kuo-Shyang Jeng; Chi-Juei Jeng; Wen-Juei Jeng; Chiung-Fang Chang; I-Shyan Sheen
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

4.  The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.

Authors:  Yu Zhu; Anmin Liu; Xuebin Zhang; Lisha Qi; Ling Zhang; Jing Xue; Yi Liu; Ping Yang
Journal:  Tumour Biol       Date:  2014-12-28

5.  Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer.

Authors:  Juliana Garcia de Oliveira; Ana Flávia Teixeira Rossi; Daniela Manchini Nizato; Aline Cristina Targa Cadamuro; Yvana Cristina Jorge; Marina Curado Valsechi; Larissa Paola Rodrigues Venâncio; Paula Rahal; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo; Ana Elizabete Silva
Journal:  Tumour Biol       Date:  2015-06-19

Review 6.  The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities.

Authors:  Qiyuan Zhuang; Hui Yang; Ying Mao
Journal:  Neurosci Bull       Date:  2022-10-13       Impact factor: 5.271

Review 7.  Therapeutic cancer vaccines.

Authors:  Cornelis J M Melief; Thorbald van Hall; Ramon Arens; Ferry Ossendorp; Sjoerd H van der Burg
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

8.  Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.

Authors:  Xiao-Wu Chen; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-06-08       Impact factor: 4.162

9.  Targeting inflammasome/IL-1 pathways for cancer immunotherapy.

Authors:  Beichu Guo; Shunjun Fu; Jinyu Zhang; Bei Liu; Zihai Li
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

10.  Identification of hub genes and outcome in colon cancer based on bioinformatics analysis.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Zichao Li; Xin Zhou; Bo Cao; Yujie Zhang; Jinqiang Liu; Zhiping Yang; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.